ASSOCIATION BETWEEN MENARCHE AGE AND MENOPAUSAL SYMPTOMS by R, Muharam et al.
Vol 10, Issue 6, 2017
Online - 2455-3891 
Print - 0974-2441
ASSOCIATION BETWEEN MENARCHE AGE AND MENOPAUSAL SYMPTOMS
MUHARAM R1*, MUHAMMAD IKHSAN2, HERDINDA ERUDITE RIZKINYA2
1Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo National General 
Hospital, Jakarta, Indonesia. 2Indonesian Reproductive Medicine Research and Training Center, Faculty of Medicine, Universitas 
Indonesia, Jakarta, Indonesia. Email: rmuharam@yahoo.com
Received: 14 February 2017, Revised and Accepted: 14 March 2017
ABSTRACT
Objective: The objective of this study was to assess the association between menarche age and menopausal symptoms.
Methods: A cross-sectional study with 100 perimenopause subjects. Every subject was assessed of their menopausal symptoms with validated 
menopause rating scale (MRS) questionnaire. Menopause symptoms were classified into somato-vegetative, psychological, and urogenital symptoms. 
Statistical analysis was used to assess menarche age and menopause symptoms associations.
Results: Out of 100 subjects, somato-vegetative, psychological, and urogenital symptoms were found in 46%, 68%, and 74% cases, respectively. 
Menarche age was varied between 10 and 17-year-old. There was a significant correlation between menarche age and psychological symptoms 
(p=0.034). However, there was no significant correlation between menarche age and somato-vegetative as well as urogenital symptoms (p=0.257; 
p=0.093).
Conclusion: There was a significant association between menarche age and psychological symptoms in perimenopause women. However, there was 
no association between menarche age and somato-vegetative as well as urogenital symptoms in perimenopause women.
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INTRODUCTION
Menopause is defined as the permanent cessation of menstruation that 
results from the loss of ovarian follicular activity and it marks the end of a 
woman’s reproductive capacity. Its retrospective diagnosis is usually made 
after 12 months of amenorrhea and may be determined genetically [1,2].
The median age of menopause has been fairly consistent over centuries 
and across modern epidemiologic studies, generally falls between 
50 and 52 years of age. There is striking consistency in the age of 
menopause across geographic and cultural groups despite significant 
disparities in other measures of reproductive health such as age of 
menarche and childbirth [3]. Several factors - including parity, oral 
contraceptive use, socioeconomic status, and smoking - have been 
identified to be correlated with the timing of natural menopause [4].
The onset of menopause is a significant life event for women, carrying 
with its medical, psychosocial, and cultural significance. More broadly, 
the perimenopausal transition, defined as the time between the onset 
of menstrual irregularity and the menopause, is a transition phase 
from fertile ovulatory cycles with well-characterized hormonal profiles 
to the postmenopause with low estrogen and progesterone and high 
gonadotrophin levels. Those hormonal imbalances may bring the 
complaint of menopausal symptoms [5].
In general, menopausal symptoms are divided into somatic, urogenital, 
and psychological symptoms which influence various aspects of 
women’s health including bone loss, urogenital atrophy, urinary tract 
infections and incontinence, increased cardiovascular risk, sexual 
dysfunction, and loss of skin elasticity [6]. The prevalence of menopausal 
symptoms may reach more than 50% and its severity may vary among 
peri- and postmenopausal women in different racial groups [7,8].
Many menopausal symptoms including somatic, urogenital, and 
psychological symptoms may be influenced by various factors. Lower 
socioeconomic, overweight and obesity, and higher parity had been 
linked to increased severity of symptoms [9].
Early menarche age may associate with longer reproductive years 
representing extended exposure to gonadal hormones in women. Recent 
publication had numerous finding regarding the age of menarche and 
menopause with depression. The results seem to be more consistent 
in association between them [10]. However, estrogen exposure may 
impact other menopausal symptoms as well. Thus, it is important to 
conduct this research to investigate whether menarche age would affect 
menopausal symptoms.
METHODS
This is a cross-sectional study to assess the association between 
menarche age and menopausal symptoms in perimenopause 
women. We collected data consecutively on 100 participants starting 
from January until March 2016. This study was conducted in Cipto 
Mangunkusumo National General Hospital, Jakarta, Indonesia.
The inclusion criteria were women age 45-55 years old and willing 
to participate. The exclusion criteria were women with a history of 
gynecological diseases that caused earlier menopause; having mentally-
ill condition; or having any illness that may affect menopausal symptoms.
The data collected in this study was primary data. Every respondent 
had been informed of the purposes of this study, the procedures, 
and data collected. Informed consents have been obtained from the 
participants. Every participant had agreed to share data collected 
regarding the publication of this study. This study had been approved 
by the Ethical Committee of Faculty of Medicine, Universitas Indonesia, 
Jakarta, Indonesia.
Data collection was done via a questionnaire that was filled by 
participant. Baseline data about participant including menarche 
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age and menopause rating scale (MRS) were obtained from every 
participant.
The MRS was developed and validated some years ago aiming at 
establishing an instrument to measure health-related quality of life 
that can easily complete by women. The aims of the MRS were to enable 
comparisons of the symptoms of aging between groups of women 
under different conditions and to compare the severity of symptoms. 
Three dimensions of symptoms/complaints were identified using 
this questionnaire including somato-vegetative, psychological, and 
urogenital factors [11].
The scoring scheme is simple; the score increases point by point with 
increasing severity of subjectively perceived symptoms in each of the 
11 items. The participant provides her personal perception by checking 
one of 5 possible boxes of severity (0 [no complaints] to 4 [very severe]) 
for each of the items. The German original MRS scale was initially 
translated and culturally adapted into English, and now also available 
in Indonesian version [11].
In this study, we categorized women who had somato-vegetative 
symptoms score 3 or more; psychological symptoms score 2 or more, 
and urogenital symptoms score 1 or more as having positive menopausal 
symptoms. Based on somato-vegetative domain, participants were 
divided into no/little symptoms (0-2), mild symptoms (3-4), moderate 
symptoms (5-8), and severe symptoms (≥9). Based on psychological 
domain, participants were divided into no/little symptoms (0-1), mild 
symptoms (2-3), moderate symptoms (4-6), and severe symptoms 
(≥7). Last, based on urogenital domain, participants were divided into 
no symptom (0), mild symptoms (1), moderate symptoms (2-3), and 
severe symptoms (≥4).
All data analysis was processed with SPSS software for Windows 
version 22. Data were analyzed descriptively and analytically using 
Spearmen test to exhibit correlation.
RESULTS
In the beginning of the study, 107 participants were enrolled in the 
study. Seven participants were excluded and the rest 100 participants 
were included into the analysis. Every participant was 45-55 years old, 
fulfilling inclusion criteria and failing exclusion criteria. Characteristics 
observed were participants’ age, menarche age, menopause age, 
smoking history, occupation, marital status, education background, 
and cumulative income. Participants’ characteristics can be viewed on 
Table 1.
Most of the participants had menarche at 14-year-old, still not 
menopause, working as employee, married, had moderate income, well-
educated, and have 2 children. Menopausal symptoms were assessed by 
MRSs and classified based on the severity. Distribution of menopausal 
symptoms can be seen in Table 2.
Nearly 46% participants were having somato-vegetative symptoms, 
68% participants were having psychological symptoms, and 
74% participants were having urogenital symptoms. Most of the 
symptomatic participants had mild somato-vegetative complaints, mild 
psychological complaints, and severe urogenital complaints.
Somato-vegetative complaints in MRS consist of hot flushes, 
heart discomfort, sleep problems, joint and muscular discomfort. 
Psychological complaints asked were depressive mood, irritability, 
anxiety, physical and mental exhaustion. Urogenital complaints 
reported were sexual problems, bladder problems, and dryness of 
vagina.
We correlate menarche age and menopausal symptoms using Spearman 
correlation test. There was a significant weak positive correlation 
between menarche age and psychological symptoms (p=0.034; 
r=0.183). However, there was no significant correlation between 
menarche age and somato-vegetative as well as urogenital symptoms 
(p=0.257; p=0.093).
Table 1: Distribution of participants characteristics


















Active smoker 9 (9)










<3 million 12 (12)
3-5 million 42 (42)
5-20 million 41 (41)
>20 million 5 (5)
Educational background
Elementary 1 (1)
Junior high school 4 (4)
Senior high school 42 (42)
Diploma/bachelor 46 (46)
Master/doctor 7 (7)







Table 2: Distribution of menopausal symptoms based on MRS

















MRS: Menopause rating scale
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DISCUSSION
This study was conducted to assess the association between menarche 
age and menopausal symptoms in perimenopausal women. To study the 
prevalence of menopausal symptoms, the MRS scale is subdivided into 
three domains. Out of a sample of 107 women who filled the MRS and 
baseline questionnaire, 100 women fulfilled the inclusion/exclusion 
criteria and were selected for the study.
Menopause has been considered as a major transition point in women’s 
reproductive and hormonal life. As hormone production by the ovaries 
gradually decreases, there is a length of time, when the levels of estrogen 
and progesterone in a woman’s body are unpredictable. However, 
many use it to cover the entire time during which the production of 
hormones by the ovaries gradually decreases and eventually stops. 
This is frequently called the perimenopausal period. For women, this 
is a gradual process rather than a sudden event and contributing to 
menopausal symptoms [12].
In this study, we collected baseline data including participants’ age, 
menarche age, menopause age, smoking history, occupation, marital 
status, education background, and cumulative income. Most of the 
participants were not menopause, had a job, married, and well-
educated.
We found the association between menarche age and psychological 
symptoms despite its weak correlation (p=0.034; r=0.183). This 
finding was similar to studies conducted earlier. Later menarche and 
earlier menopause were both associated with depression [13]. A study 
conducted in Finland reported that there was increased odd ratio of 
depression in women who had menarche at age 16 or older. Similarly, a 
study conducted in the US found an association between later menarche 
and increased depressive symptoms [14,15].
The hypothesis underlying the mechanisms is estrogen deficiency. 
Estrogen deficiency might decrease serotonergic activity with alteration 
of mood like depression [12]. It is known that the change in circulating 
estrogen during puberty is also related to the disturbances in mood and 
the estrogen in puberty affects adolescent brain in mice [16]. Estrogen 
is known to interact with the serotonergic system and processes 
related to norepinephrine in menopausal women. Among the receptors 
for estrogen, the beta-receptor plays a major role in emotional 
processes associated with the serotonergic system. As estrogen lessens 
monoamine oxidase, the level of serotonin increases [17].
In addition, evidence showed that hormonal imbalance in women 
during pregnancy also contributed to mood disorder. The study 
showed that depression is one of the most common mood disorders 
seen in pregnant women [18]. Postpartum period is also a vulnerable 
time for women to develop depressive symptoms. Postpartum 
depression is the most common in the first 6 months and correlates 
with hormonal imbalance [19]. This hormonal imbalance may similar 
to menopause transition phase that contributes to psychological 
symptoms.
CONCLUSION
There was a significant weak association between menarche age and 
psychological symptoms in perimenopause women. However, there 
was no association between menarche age and somato-vegetative as 
well as urogenital symptoms in perimenopause women.
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